MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12876-022-02507-3

Медицинская библиотека · BMC gastroenterology · 2022

New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review.

Alhumaid Saad, Al Mutair Abbas, Rabaan Ali A, ALShakhs Fatemah M, Choudhary Om Prakash, Yong Shin Jie, Nainu Firzan, Khan Amjad, Muhammad Javed, Alhelal Fadil, Al Khamees Mohammed Hussain, Alsouaib Hussain Ahmed, Al Majhad Ahmed Salman, Al-Tarfi Hassan Redha, ALyasin Ali Hussain, Alatiyyah Yaqoub Yousef, Alsultan Ali Ahmed, Alessa Mohammed Essa, Alessa Mustafa Essa, Alissa Mohammed Ahmed, Alsayegh Emad Hassan, Alshakhs Hassan N, Al Samaeel Haidar Abdullah, AlShayeb Rugayah Ahmed, Alnami Dalal Ahmed, Alhassan Hussain Ali, Alabdullah Abdulaziz Abdullah, Alhmed Ayat Hussain, AlDera Faisal Hussain, Hajissa Khalid, Al-Tawfiq Jaffar A, Al-Omari Awad

СтатьяСистематический обзорПеревод в очереди

Аннотация

BACKGROUND

Liver diseases post-COVID-19 vaccination is extremely rare but can occur. A growing body of evidence has indicated that portal vein thrombosis, autoimmune hepatitis, raised liver enzymes and liver injuries, etc., may be potential consequence of COVID-19 vaccines.

OBJECTIVES

To describe the results of a systematic review for new-onset and relapsed liver disease following COVID-19 vaccination.

METHODS

For this systematic review, we searched Proquest, Medline, Embase, PubMed, CINAHL, Wiley online library, Scopus and Nature through the Preferred Reporting Items for Systematic Reviews and Meta Analyses PRISMA guideline for studies on the incidence of new onset or relapsed liver diseases post-COVID-19 vaccination, published from December 1, 2020 to July 31, 2022, with English language restriction.

RESULTS

Two hundred seventy-five cases from one hundred and eighteen articles were included in the qualitative synthesis of this systematic review. Autoimmune hepatitis (138 cases) was the most frequent pathology observed post-COVID-19 vaccination, followed by portal vein thrombosis (52 cases), raised liver enzymes (26 cases) and liver injury (21 cases). Other cases include splanchnic vein thrombosis, acute cellular rejection of the liver, jaundice, hepatomegaly, acute hepatic failure and hepatic porphyria. Mortality was reported in any of the included cases for acute hepatic failure (n = 4, 50%), portal vein thrombosis (n = 25, 48.1%), splanchnic vein thrombosis (n = 6, 42.8%), jaundice (n = 1, 12.5%), raised liver enzymes (n = 2, 7.7%), and autoimmune hepatitis (n = 3, 2.2%). Most patients were easily treated without any serious complications, recovered and did not require long-term hepatic therapy.

CONCLUSION

Reported evidence of liver diseases post-COIVD-19 vaccination should not discourage vaccination against this worldwide pandemic. The number of reported cases is relatively very small in relation to the hundreds of millions of vaccinations that have occurred and the protective benefits offered by COVID-19 vaccination far outweigh the risks.

Для цитирования: Alhumaid Saad, Al Mutair Abbas, Rabaan Ali A, ALShakhs Fatemah M, Choudhary Om Prakash, Yong Shin Jie, Nainu Firzan, Khan Amjad, Muhammad Javed, Alhelal Fadil, Al Khamees Mohammed Hussain, Alsouaib Hussain Ahmed, Al Majhad Ahmed Salman, Al-Tarfi Hassan Redha, ALyasin Ali Hussain, Alatiyyah Yaqoub Yousef, Alsultan Ali Ahmed, Alessa Mohammed Essa, Alessa Mustafa Essa, Alissa Mohammed Ahmed, Alsayegh Emad Hassan, Alshakhs Hassan N, Al Samaeel Haidar Abdullah, AlShayeb Rugayah Ahmed, Alnami Dalal Ahmed, Alhassan Hussain Ali, Alabdullah Abdulaziz Abdullah, Alhmed Ayat Hussain, AlDera Faisal Hussain, Hajissa Khalid, Al-Tawfiq Jaffar A, Al-Omari Awad. New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review.. BMC gastroenterology. 2022. DOI: 10.1186/s12876-022-02507-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.